Healthcare entity
regulation is the sole category represented across all 1 tracked stories. Recce Pharmaceuticals is most often covered alongside National Institute of Industrial Property (INPI), which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window.
Last mentioned: Mar 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Recce Pharmaceuticals is most often covered alongside National Institute of Industrial Property (INPI), which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention Recce Pharmaceuticals, all published on March 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Recce Pharmaceuticals. Shared-story counts are live from our verified record — not editorial picks.
Brazil Patent Grant
INPI grants patent for Recce's anti-infectives platform.
Clinical Progress
Ongoing Phase I/II trials for RECCE® 327 in sepsis and burn wounds.
Global IP Expansion
Recce secures similar patent protections in the US, EU, and Japan.
Recce Pharmaceuticals has been granted a key patent in Brazil for its synthetic anti-infectives platform, covering the manufacturing process for its lead candidates. This move secures intellectual property protection in South America's largest economy, bolstering the company's global strategy against antimicrobial resistance.
Recce Pharmaceuticals is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
